Micar Innovation (Micar21) Ltd., Persenk 34B, 1407 Sofia, Bulgaria.
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Texas at El Paso, 1101 N Campbell Street, El Paso, Texas 79968, United States.
J Chem Inf Model. 2021 Dec 27;61(12):6079-6084. doi: 10.1021/acs.jcim.1c01242. Epub 2021 Nov 22.
The N501Y and K417N mutations in the spike protein of SARS-CoV-2 and their combination gave rise to questions, but the data on their mechanism of action at the molecular level were limited. In this study, we present free energy perturbation (FEP) calculations, performed at the end of December 2020, for the interactions of the spike S1 receptor-binding domain (RBD) with both the ACE2 receptor and an antibody derived from COVID-19 patients. Our results showed that the S1 RBD-ACE2 interactions were significantly increased whereas those with the STE90-C11 antibody dramatically decreased. The K417N mutation in a combination with N501Y fully abolished the antibody effect. However, Lys417Asn seems to have a compensatory mechanism of action increasing the S1 RBD-ACE2 free energy of binding. This may explain the increased spread of the virus observed in the U.K. and South Africa and also gives rise to an important question regarding the possible human immune response and the success of the already available vaccines. Notably, when the experimental data became available confirming our calculations, it was demonstrated that protein-protein FEP can be a useful tool for providing urgent data to the scientific community.
SARS-CoV-2 刺突蛋白中的 N501Y 和 K417N 突变及其组合引发了诸多疑问,但关于其在分子水平上作用机制的数据有限。在这项研究中,我们展示了 2020 年 12 月底进行的自由能微扰(FEP)计算,用于研究刺突 S1 受体结合域(RBD)与 ACE2 受体和 COVID-19 患者来源的抗体的相互作用。我们的结果表明,S1 RBD-ACE2 的相互作用显著增强,而与 STE90-C11 抗体的相互作用则急剧下降。N501Y 与 K417N 突变的组合完全消除了抗体的作用。然而,Lys417Asn 似乎具有一种补偿作用机制,增加了 S1 RBD-ACE2 的结合自由能。这可能解释了在英国和南非观察到的病毒传播增加,也引发了一个关于可能的人体免疫反应和现有疫苗成功的重要问题。值得注意的是,当实验数据证实了我们的计算结果时,证明了蛋白质-蛋白质 FEP 可以成为向科学界提供紧急数据的有用工具。